Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Howard Fingert
Introduction
Howard Fingert is a notable inventor based in Berkeley Heights, NJ (US). He has made significant contributions to the field of medical treatments, particularly in addressing bcl-2 related disorders. His work focuses on innovative methods that utilize bcl-2 antisense oligomers to combat various forms of cancer and other cell-proliferative disorders.
Latest Patents
Howard Fingert holds a patent for "Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers." This invention is directed towards the use of bcl-2 antisense oligomers to treat and prevent disorders related to bcl-2, including cancers, tumors, and carcinomas. The patent outlines methods for administering these oligomers at high doses and emphasizes their potential to enhance the sensitivity of subjects to cancer therapeutics. Additionally, it includes pharmaceutical compositions that may combine bcl-2 antisense oligomers with cancer therapeutic agents.
Career Highlights
Fingert's career is marked by his dedication to advancing medical science through innovative treatments. He has been instrumental in developing methods that could potentially change the landscape of cancer therapy. His work is characterized by a commitment to improving patient outcomes through targeted treatment strategies.
Collaborations
Howard Fingert has collaborated with notable professionals in his field, including Raymond P Warrell and Robert E Klem. These collaborations have likely contributed to the depth and impact of his research and inventions.
Conclusion
In summary, Howard Fingert's contributions to the field of medical treatment through his patent on bcl-2 antisense oligomers highlight his innovative spirit and dedication to improving cancer therapies. His work continues to pave the way for advancements in the treatment of serious health conditions.